National Cancer Institute to Grant Exclusive Patent License to Moonlight Bio for Engineered T Cell Therapies

Summary

The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Moonlight Bio, Inc. for the development and commercialization of engineered T cell therapies for cancer treatment.